Synthesis and Biological Evaluation of Itraconazole Derivatives: Design in an Old Scaffold.

https://doi.org/10.1021/acs.inorgchem.5c02730

P301

J. Med. Mycol. 2025, 101583.

A One Health Perspective on Diutina catenulata: Phenotypic Traits, Stress Sensitivity, and Virulence Across Diverse Isolates.

https://doi.org/10.1016/j.mycmed.2025.101583

P278

Antimicrob. Agents Chemother. 2024, e0002224.

Precise genome editing underlines the distinct contributions of mutations in ERG11, ERG3, MRR1, and TAC1 genes to antifungal resistance in Candida parapsilosis.

https://doi.org/10.1128/aac.00022-24

P246

Microorganisms. 2022, 10, 104.

Impact of TR34/L98H, TR46/Y121F/T289A and TR53 alterations in azole‐resistant Aspergillus fumigatus on sterol composition and modifications after In Vitro exposure to itraconazole and voriconazole.

https://doi.org/10.3390/microorganisms10010104

P215

Sci. Rep. 2020, 10, 6211.

In vitro immune responses of human PBMCs against Candida albicans reveals fungal and leucocyte phenotypes associated with fungal persistence.

doi: 10.1038/s41598-020-63344-6

P194

Hum. Immunol. 2019, 80, 999-1005.

Double positive CD4+CD8+ T cells are part of the adaptive immune response against Candida albicans.

doi: 10.1016/j.humimm.2019.09.008

P161

Infect. Immun. 2017, 85, e00807-16;

Specific Human and Candida Cellular Interactions Lead to Controlled or Persistent Infection Outcomes During Granuloma-like Formation.

Misme-Aucouturier, B. | Albassier, M. | Alvarez-Rueda, N. | Le Pape P.

doi: 10.1128/IAI.00807-16.

P105

PLoS ONE, 2012, 7(6), e40185, 1-13.

First Human Model of In Vitro Candida albicans Persistence within Granuloma for the Reliable Study of Host-Fungi Interactions.